Kuh, Sung-Uk
(Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.)
,
Kim, Young-Soo
(Kwanghye Spine Center, Seoul, Korea.)
,
Cho, Young-Eun
(Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.)
,
Yoon, Young-Sul
(Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.)
,
Jin, Byung-Ho
(Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.)
,
Kim, Keun-Su
(Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.)
,
Chin, Dong-Kyu
(Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.)
The herniated lumbar disc (HLD) in adolescent patients is characterized by typical discogenic pain that originates from a soft herniated disc. It is frequently related to back trauma, and sometimes it is also combined with a degenerative process and a bony spur such as posterior Schmorl's node. Chem...
The herniated lumbar disc (HLD) in adolescent patients is characterized by typical discogenic pain that originates from a soft herniated disc. It is frequently related to back trauma, and sometimes it is also combined with a degenerative process and a bony spur such as posterior Schmorl's node. Chemonucleolysis is an excellent minimally invasive treatment having these criteria: leg pain rather than back pain, severe limitation on the straight leg raising test (SLRT), and soft disc protrusion on computed tomography (CT). Microsurgical discectomy is useful in the cases of extruded or sequestered HLD and lateral recess stenosis due to bony spur because the nerve root is not decompressed with chymopapain. Spinal fusion, like as PLIF, should be considered in the cases of severe disc degeneration, instability, and stenosis due to posterior central bony spur. In our study, 185 adolescent patients, whose follow-up period was more than 1 year (the range was 1 - 4 years), underwent spinal surgery due to HLD from March, 1998 to December, 2002 at our institute. Among these cases, we performed chemonucleolysis in 65 cases, microsurgical discectomy in 94 cases, and posterior lumbar interbody fusion (PLIF) with cages in 33 cases including 7 reoperation cases. The clinical success rate was 91% for chemonucleolysis, 95% for microsurgical disectomy, and 89% for PLIF with cages, and there were no nonunion cases for the PLIF patients with cages. In adolescent HLD, chemonucleolysis was the 1st choice of treatment because the soft adolescent HLD was effectively treated with chemonucleolysis, especially when the patient satisfied the chemonucleolysis indications.
The herniated lumbar disc (HLD) in adolescent patients is characterized by typical discogenic pain that originates from a soft herniated disc. It is frequently related to back trauma, and sometimes it is also combined with a degenerative process and a bony spur such as posterior Schmorl's node. Chemonucleolysis is an excellent minimally invasive treatment having these criteria: leg pain rather than back pain, severe limitation on the straight leg raising test (SLRT), and soft disc protrusion on computed tomography (CT). Microsurgical discectomy is useful in the cases of extruded or sequestered HLD and lateral recess stenosis due to bony spur because the nerve root is not decompressed with chymopapain. Spinal fusion, like as PLIF, should be considered in the cases of severe disc degeneration, instability, and stenosis due to posterior central bony spur. In our study, 185 adolescent patients, whose follow-up period was more than 1 year (the range was 1 - 4 years), underwent spinal surgery due to HLD from March, 1998 to December, 2002 at our institute. Among these cases, we performed chemonucleolysis in 65 cases, microsurgical discectomy in 94 cases, and posterior lumbar interbody fusion (PLIF) with cages in 33 cases including 7 reoperation cases. The clinical success rate was 91% for chemonucleolysis, 95% for microsurgical disectomy, and 89% for PLIF with cages, and there were no nonunion cases for the PLIF patients with cages. In adolescent HLD, chemonucleolysis was the 1st choice of treatment because the soft adolescent HLD was effectively treated with chemonucleolysis, especially when the patient satisfied the chemonucleolysis indications.
1 Epstein JA Epstein NE Marc J Rosenthal AD Lavine LS Lumbar intervertebral disk herniation in teenage children: recognition and management of associated anomalies Spine 1984 9 427 432 6474257
2 Ishihara H Matsui H Hirano N Tsuji H Lumbar intervertebral disc herniation in children less than 16 years of age. Long-term follow-up study of surgically managed cases Spine 1997 22 2044 2049 9306537
3 Kim YS Chin DK Yoon DH Jin BH Cho YE Predictors of successful outcome for lumbar chemonucleolysis: analysis of 3000 cases during the past 14 years Neurosurgery 2002 51 123 128
4 Lorenz M McCulloch J Chemonucleolysis for herniated nucleus pulposus in adolescents J Bone Joint Surg Am 1985 67 1402 1404 4077911
5 Martinez-Lage JF Poza M Arcas P Avulsed lumbar vertebral rim plate in an adolescent: trauma or malformation? Child's Nerv Syst 1998 14 131 134 9579870
6 Parisini P Di Silvestre M Greggi T Miglietta A Paderni S Lumbar disc excision in children and adolescents Spine 2001 26 1997 2000 11547199
7 Bradbury N Wilson LF Mulholland RC Adolescent disc protrusions. A long-term follow-up of surgery compared to chymopapain Spine 1996 21 372 377 8742215
8 Lee JY Ernestus RI Schroder R Klug N Histological study of lumbar intervertebral disc herniation in adolescents Acta Neurochir (Wien) 2000 142 1107 1110 11129531
9 Clarke NM Cleak DK Intervertebral lumbar disc prolapse in children and adolescents J Pediatr Orthop 1983 3 202 206 6863525
10 Van Alphen HA Braakman R Bezemer PD Broere G Berfelo MW Chemonucleolysis versus discectomy: a randomized multicenter trial J Neurosurg 1989 70 869 875 2654335
11 Javid MJ Chemonucleolysis versus laminectomy. A cohort comparison of effectiveness and charges Spine 1995 20 2016 2022 8578379
12 Bayliss MT Jonestone B O'Brien JP Proteoglycan synthesis in the human intervertebral disc, Variation with age, region and pathology Spine 1988 13 972 981 3206304
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.